Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer.

Cochrane database of systematic reviews (Online)

Volumn 5, Issue , 2011, Pages

  Shang, Pan Feng ^a   Kwong, Joey ^b   Wang, Zhi Ping ^b   Tian, Jinhui ^b   Jiang, Lei ^b   Yang, Kehu ^b   Yue, Zhong Jin ^b   Tian, Jun Qiang ^b  

^a LANZHOU UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BCG VACCINE; EPIRUBICIN; IMMUNOLOGICAL ADJUVANT;

BLADDER TUMOR; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; META ANALYSIS; MORTALITY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TUMOR RECURRENCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; BCG VACCINE; EPIRUBICIN; HUMANS; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 79959500775     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)